ConjuChem enters the biotech graveyard

ConjuChem has filed for bankruptcy, with all its assets being liquidated and all executives resigning their posts. The Montreal-based company has been in financial turmoil for some time, and had been looking for buyers since January 2010. With no offers materializing, the company will have to shut its doors. ConjuChem was pursuing the developing long-acting diabetes treatments, and there's no word yet on what will happen to the company's portfolio of drugs. ConjuChem is the latest in a...